Our Private Equity Group is considered the go-to practice for complex, bespoke and firm-defining transactions. With clients ranging from the world’s leading institutional asset managers to prominent middle-market private equity and growth equity firms, we offer comprehensive advice to general partners, limited partners, co-investors and other equity stakeholders, as well as portfolio companies, lenders and financial sponsor groups. The depth and continuity of our relationships across the industry gives us a nuanced understanding of each client’s objectives and allows us to provide seamless, efficient counsel across the investment lifecycle.
Nutraceutical to Be Acquired by HGGC
- Client News
- May 18, 2017
Paul, Weiss is representing Nutraceutical International Corporation in its $446 million acquisition by HGGC, LLC, a leading middle-market private equity firm. The transaction includes cash as well as debt. Under the terms of the agreement, announced on May 22, Nutraceutical stockholders will receive $41.80 in cash for each outstanding share of Nutraceutical common stock, which represents a 49 percent premium to Nutraceutical’s closing stock price on May 19, and a 15.6 percent premium to its all-time high closing stock price. The transaction is expected to close in the second half of 2017. Nutraceutical manufactures and markets branded nutritional supplements and bulk formulations for sale to health food stores and other nutritional industries.
The Paul, Weiss team included, among others, corporate partners Jeffrey Marell, Ted Ackerman and David Huntington and counsel Frances Mi; employee benefits partner Lawrence Witdorchic; real estate partner Salvatore Gogliormella; intellectual property partner Claudine Meredith-Goujon; antirust counsel Marta Kelly; and environmental counsel William O’Brien.